Unknown

Dataset Information

0

Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial.


ABSTRACT:

Background

We aimed to compare long-term outcomes in Polish patients with atrial fibrillation (AF) according to oral anticoagulation (OAC) type and to evaluate the predictive value of common thromboembolic and bleeding risk scores.

Methods

Data from the CRAFT trial (NCT02987062) were included. The primary study endpoint was major adverse event (MAE; all-cause death, thromboembolic and hemorrhagic event) during the mean four-year follow-up period.

Results

Out of 2983 patients with available follow-up data, 1686 (56%) were prescribed with vitamin K antagonist (VKA), 891 (30%) with rivaroxaban and 406 (14%) with dabigatran. Predominance of elderly and female patients with previous history of thromboembolic and hemorrhagic events was observed within rivaroxaban (vs. other OAC) group. Higher rate of MAEs and its components was observed in patients on VKA followed by rivaroxaban as compared to patients on dabigatran (43% vs. 42% vs. 31%, p < 0.01). After group matching based on clinical characteristics, higher risk of hemorrhagic events in VKA (vs. dabigatran) and rivaroxaban (vs. dabigatran) group were observed. The available thromboembolic (CHA2DS2-VASs, ATRIA, R2CHADS2) and bleeding (HAS-BLED, ATRIA, ORBIT) risk scores showed poor prediction value.

Conclusions

Despite no difference in the thromboembolic event rate, treatment with VKA and rivaroxaban was associated with a significant increase in the risk of hemorrhagic events.

SUBMITTER: Balsam P 

PROVIDER: S-EPMC8073861 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5968005 | biostudies-literature
| S-EPMC5562962 | biostudies-literature
| S-EPMC10700826 | biostudies-literature
| S-EPMC8222517 | biostudies-literature
| S-EPMC9579845 | biostudies-literature
| S-EPMC8828824 | biostudies-literature
| S-EPMC1860779 | biostudies-literature
| S-EPMC4219336 | biostudies-literature
| S-EPMC8442883 | biostudies-literature
| S-EPMC6326474 | biostudies-literature